Korsana Biosciences, Inc. (KRSA) stock
KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$33.27+0.77 (+2.37%)
Close on Nov 18, 2026Market cap $155.75MP/E –Yield –
Korsana Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Korsana Biosciences's market cap was $135.52M on Nov 11, 2026, against $40.87M a year earlier. Over the last 5 years it ranged from $11.76M to $521.44M, with a median of $61.48M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $135.52M | +312.6% |
| 2025 | Dec 31, 2025 | $32.85M | -42.4% |
| 2024 | Dec 31, 2024 | $57.05M | -0.5% |
| 2023 | Dec 29, 2023 | $57.34M | -71.3% |
| 2022 | Dec 30, 2022 | $199.78M | -61.7% |
| 2021 | Dec 31, 2021 | $521.44M | -28.3% |
| 2020 | Dec 31, 2020 | $727.44M | +39.1% |
| 2019 | Dec 31, 2019 | $522.99M | – |
See a number that looks wrong?